Xeris Biopharma Holdings, Inc.
XERS
$6.96
-$0.22-3.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.98% | -23.57% | -33.10% | -1.15% | 5.19% |
| Total Receivables | 30.66% | 25.00% | 23.83% | 3.11% | -10.50% |
| Inventory | 49.52% | 56.55% | 28.90% | 24.04% | 18.29% |
| Prepaid Expenses | 56.95% | -18.93% | -20.98% | 28.95% | -10.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 37.60% | 8.95% | -5.65% | 7.29% | 3.00% |
|
|
|||||
| Total Current Assets | 37.60% | 8.95% | -5.65% | 7.29% | 3.00% |
| Net Property, Plant & Equipment | -4.10% | -3.52% | -3.54% | -3.30% | -4.13% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -10.67% | -10.39% | -10.13% | -9.88% | -9.64% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.31% | -7.86% | 10.49% | 19.10% | 13.23% |
| Total Assets | 15.29% | 0.89% | -6.29% | 0.14% | -2.04% |
|
|
|||||
| Total Accounts Payable | -12.40% | 63.19% | -10.46% | -80.20% | -38.31% |
| Total Accrued Expenses | 85.23% | 24.31% | 12.98% | 24.40% | 11.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -70.64% | 16.00% | 290.92% | 506.07% | 791.76% |
| Total Finance Division Other Current Liabilities | 18.83% | 21.58% | 20.99% | -41.49% | -44.65% |
| Total Other Current Liabilities | 18.83% | 21.58% | 20.99% | -41.49% | -44.65% |
| Total Current Liabilities | 27.67% | 26.07% | 30.09% | 5.52% | 4.57% |
|
|
|||||
| Total Current Liabilities | 27.67% | 26.07% | 30.09% | 5.52% | 4.57% |
| Long-Term Debt | 1.50% | -5.14% | -5.17% | 13.66% | 13.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.90% | -4.63% | -4.44% | -4.33% | -4.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -60.32% | -29.74% | -44.04% | -76.85% | -24.37% |
| Total Liabilities | 6.19% | 0.85% | 1.38% | 7.07% | 7.87% |
|
|
|||||
| Common Stock & APIC | 6.75% | 5.06% | 3.05% | 5.24% | 5.08% |
| Retained Earnings | -2.35% | -4.92% | -7.09% | -8.89% | -10.46% |
| Treasury Stock & Other | -56.25% | 22.58% | 30.56% | 0.00% | 68.00% |
| Total Common Equity | 96.96% | -0.09% | -282.74% | -336.67% | -832.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 96.96% | -0.09% | -282.74% | -336.67% | -832.81% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 96.96% | -0.09% | -282.74% | -336.67% | -832.81% |
|
|
|||||